← Contracts
PT
1732/2025- Aquisição de L53 - Letrozol [2,5mg; comp] e R1117- Ranibizumab (intravítreo) [10 mg/ ml; 0,165 ml; seringa] doentes em tratamento.
ID 11744677
· Portal BASE
Price
Base Price
€19,693
.00
Effective Price
€19,218
.00
-2.4%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A.
NIF 500063524
Dates
- Publication
- 25 Sep 2025
- Celebration
- 25 Sep 2025
Contracting Entity
Centro Hospitalar Universitário de Lisboa Norte, EPE
NIF 508481287
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 35 · MEDIUM RISK
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
- Base price
- 19693.0
- Threshold
- 20000.0
- Rule
- A5 threshold splitting: price within 5% below 20000.0
Detected 2026-03-06